LCCCX
Price
$26.04
Change
+$0.46 (+1.80%)
Updated
Apr 23 closing price
Net Assets
12.91B
VFINX
Price
$496.38
Change
+$8.15 (+1.67%)
Updated
Apr 23 closing price
Net Assets
1.32T
Ad is loading...

LCCCX vs VFINX

Header iconLCCCX vs VFINX Comparison
Open Charts LCCCX vs VFINXBanner chart's image
Columbia Contrarian Core C
Price$26.04
Change+$0.46 (+1.80%)
VolumeN/A
Net Assets12.91B
Vanguard 500 Index Investor
Price$496.38
Change+$8.15 (+1.67%)
VolumeN/A
Net Assets1.32T
LCCCX vs VFINX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LCCCX vs. VFINX commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LCCCX is a Buy and VFINX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VFINX has more cash in the bank: 1.32T vs. LCCCX (12.9B). VFINX pays higher dividends than LCCCX: VFINX (1.24) vs LCCCX (0.00). LCCCX was incepted earlier than VFINX: LCCCX (22 years) vs VFINX (49 years). LCCCX (1.74) is less costly to investors than VFINX (0.14). LCCCX is a more actively managed with annual turnover of: 51.00 vs. VFINX (2.00). VFINX has a lower initial minimum investment than LCCCX: VFINX (0) vs LCCCX (2000). VFINX annual gain was more profitable for investors over the last year : 4.33 vs. LCCCX (-8.58). VFINX return over 5 years is better than : 86.46 vs. LCCCX (18.43).
LCCCXVFINXLCCCX / VFINX
Total Expense Ratio1.740.141,243%
Annual Report Gross Expense Ratio1.740.141,243%
Fund Existence22 years49 years-
Gain YTD-10.871-10.048108%
Front LoadN/AN/A-
Min. Initial Investment20000-
Min. Initial Investment IRAN/AN/A-
Net Assets12.9B1.32T1%
Annual Yield % from dividends0.001.24-
Returns for 1 year-8.584.33-198%
Returns for 3 years-1.2423.87-5%
Returns for 5 years18.4386.4621%
Returns for 10 years24.63150.1316%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RGLS2.550.23
+9.70%
Regulus Therapeutics
BOOT96.863.54
+3.79%
Boot Barn Holdings
IMNM8.480.29
+3.54%
Immunome
RS283.113.02
+1.08%
Reliance
EVGN1.09-0.03
-2.68%
Evogene Ltd.